You do not need to wait at all. The CDC and other major health authorities say you can get your flu shot and COVID shot on the same day, and a growing body of randomized trial data supports that recommendation. There is no minimum spacing interval between the two vaccines, and getting them simultaneously may even have a slight immunological advantage over spacing them out. That said, the picture is more nuanced than a simple “go ahead,” especially when it comes to side effects, which arm to use, and how the advice applies to specific groups.
Why There Is No Required Waiting Period
Both COVID vaccines (whether mRNA or protein-based) and standard injectable flu vaccines are non-live vaccines. A narrative review on optimal vaccination timing published in 2025 states the principle plainly: there is no evidence that non-live vaccines, including respiratory vaccines, interfere with the immune responses to other vaccines, and any non-live vaccine can generally be administered simultaneously or at any time before or after any other live or non-live vaccine.1PubMed Central. Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncyttal Virus This is the immunological foundation for the CDC’s current guidance: you can receive both shots at the same visit, or space them by any number of days, depending entirely on what is convenient for you.
This approach is not new or experimental. Giving multiple non-live vaccines in a single visit has been standard practice in pediatric medicine for decades, and a broad survey of the coadministration literature confirms that the practice has proven safe and effective in improving vaccination coverage.2PubMed Central. Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature The same principle has been validated for other adult vaccines too. A systematic review of HPV vaccine coadministration with vaccines like meningococcal conjugate and hepatitis B found that immune responses were preserved and safety was acceptable across multiple studies.3PubMed. Systematic review of human papillomavirus vaccine coadministration COVID and flu vaccines are just the latest pair to go through this same validation process.
What Happens to Your Immune Response When You Get Both at Once
One of the biggest concerns people have about getting two vaccines simultaneously is that the immune system will be “spread too thin” and neither shot will work as well. The evidence largely contradicts that worry, though the picture has a wrinkle worth knowing about.
A systematic review with comparative insights from G7 countries found that same-day coadministration of COVID and influenza vaccines maintains strong antibody responses without reducing immunogenicity for either vaccine. In fact, same-day administration appeared to enhance antibody responses to COVID without interfering with the flu response.4PubMed Central. COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries A separate study looking specifically at antibody types found that IgG1 responses to the SARS-CoV-2 spike protein were actually higher both at peak immunogenicity and six months later when the two vaccines were given concurrently, compared to giving them separately.5PubMed Central. Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses The researchers suggested that getting both vaccines at once may produce more durable COVID antibody responses.
The wrinkle is more subtle. A study examining coadministration of an mRNA COVID vaccine with influenza vaccine (and in some cases a pneumococcal vaccine too) found that while virus-neutralizing antibody responses were essentially equivalent across groups, the fold-rise in anti-spike IgG was modestly lower in the coadministration groups compared to the COVID-vaccine-only group.6PubMed Central. Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines The key detail here is that the neutralizing activity, which is what actually correlates with protection against infection, was not significantly affected. So while one particular measure of antibody response dipped slightly, the functional immune protection held up.
A similar pattern appeared in an earlier trial of the protein-based COVID vaccine NVX-CoV2373. When coadministered with a flu shot, a reduction in antibody responses to the COVID vaccine was noted, yet the vaccine efficacy in participants under 65 was still estimated at about 88%, closely tracking the roughly 90% efficacy seen in the main study.7PubMed Central. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines In other words, even when lab-measured antibody numbers show a slight dip, the real-world protection stays in the same range.
Side Effects Are a Bit More Common, but Not More Serious
If you get both shots in one visit, you are somewhat more likely to feel crummy for a day or two compared to getting just one. But “more likely” does not mean “more dangerous.” The side-effect profile remains dominated by the mild, short-lived reactions you would expect from either vaccine alone.
A large U.S. surveillance study found that people who received a flu shot alongside either the Pfizer or Moderna COVID booster were slightly more likely to report a systemic reaction in the following week compared to those who received the COVID booster alone. The increase was small: the adjusted odds were about 1.08 for the Pfizer combination and 1.11 for Moderna.8JAMA Network Open. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US To put that in perspective, that is roughly a single-digit percentage-point increase in your chance of symptoms like fatigue or headache.
The NVX-CoV2373 coadministration trial saw a more noticeable bump: injection-site tenderness was reported by about 65% of the coadministration group versus 53% of the COVID-vaccine-only group, and fatigue hit about 28% versus 19%.7PubMed Central. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines Those differences are real, but the reactions resolved on their own and stayed in the “annoying but not alarming” category.
A review of VAERS data covering roughly a year of coadministration reports found over 2,400 adverse event reports following simultaneous mRNA COVID and seasonal flu vaccination. About 16% were classified as serious, and the most common symptoms in non-serious reports were injection-site reactions, headache, and pain.9Vaccine. Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022 It is worth remembering that VAERS collects any adverse event reported after vaccination, whether or not the vaccine caused it, so these figures represent reported events rather than confirmed vaccine reactions. Still, the overall pattern showed no surprising safety signals beyond what is seen with either vaccine individually.
Does It Matter Which Arm Gets Which Shot?
When you sit down for two injections, your provider might ask whether you want them in the same arm or one in each. People have strong intuitions about this: some assume the same arm doubles the soreness; others worry that different arms split the immune system’s attention. The research says it mostly does not matter.
A human trial directly comparing same-arm and different-arm coadministration of influenza and bivalent COVID vaccines found that the antibody responses to both vaccines were similar regardless of which approach was used. The COVID response was slightly higher in the same-arm group, but the difference was not large enough to confirm it was a real advantage rather than statistical noise.10PubMed Central. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses
A mouse study looking at the same question found a similar story: no significant difference in antibody levels between the two approaches for most vaccine types. The one exception was that contralateral (different-arm) boosting with mRNA vaccines produced marginally higher functional antibody levels in mice, though the difference was small. Interestingly, same-arm vaccination did stimulate more immune cell activity in the nearby lymph node, which suggests some local biological differences that do not necessarily translate to differences in protection.11PubMed Central. Impact of Extended Dosing Intervals and Ipsilateral Versus Contralateral Boosting on mRNA Vaccine Immunogenicity in Mice
From a practical standpoint, pick whichever arrangement feels more comfortable. If you hate having both arms sore, put both shots in the arm you use less. If you would rather spread the soreness, go one in each. The immune outcome is effectively the same.
When Spacing Might Still Make Sense
Even though there is no immunological need to wait, some people and some situations benefit from scheduling the two shots a few days or weeks apart. The reasons are practical rather than medical.
If you tend to have strong side effects from either vaccine, getting both on the same day can make for a rough 24 to 48 hours. Spacing them by even a week or two lets you isolate which vaccine caused which reaction, which is useful information if you ever need to report a side effect or decide whether to repeat a particular vaccine next year. It also means you only feel bad once per visit instead of stacking two rounds of fatigue and arm soreness.
People who are immunocompromised sometimes prefer to space their vaccines so their care team can monitor each response individually, although the general guidance for non-live vaccines still applies. The same study that found enhanced spike-specific antibody responses from concurrent administration was conducted in a general population, and the researchers did not single out immunocompromised individuals as needing a different approach.5PubMed Central. Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses Still, if you are on immunosuppressive therapy, your doctor may have specific recommendations about timing that override the general advice.
There is also a seasonal timing question worth thinking about. Flu activity in the U.S. typically peaks between December and February, and both flu and COVID vaccines take about two weeks to build full protection. If you are getting your flu shot in early September and your updated COVID shot is not available until mid-October, there is no reason to delay the flu shot. Get each one as soon as it is available. The “should I wait?” question is only relevant when both are available at the same time and you are deciding whether to combine or separate the visits.
Why Doctors Push for Same-Day Vaccination
Public health officials have a strong practical reason for encouraging coadministration: every extra visit you have to schedule is an opportunity to skip the second one entirely. Data on U.S. adults from the 2023-24 season showed that only about one in five received both COVID and flu vaccines, even though uptake of coadministration among those who did get a COVID shot had climbed to nearly half.12Open Forum Infectious Diseases. P-1593. Immunogenicity and Safety of Concomitant Versus Sequential COVID-19 and Influenza Vaccination Strategies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials The gap between people who intend to get vaccinated and people who follow through on a second appointment is well documented.
Among older adults on Medicare, coadministration rates rose from about 11% to nearly 37% between two study periods as comfort with the practice grew. Certain groups were more likely to get both shots at once: beneficiaries with dementia and those in rural counties, both populations for whom returning for a second visit poses logistical challenges, coadministered at higher rates. Meanwhile, cancer patients were somewhat less likely to coadminister.13PubMed Central. COVID-19 and influenza vaccine co-administration among older U.S. adults That pattern makes intuitive sense: the harder it is for you to get to a pharmacy or clinic, the more valuable a single trip becomes.
Research into underserved populations has also found that the idea of a combination vaccine, one shot covering both COVID and flu, generated real interest as a tool for increasing vaccination coverage in communities where uptake is historically low.14PubMed Central. Underserved population acceptance of combination influenza-COVID-19 booster vaccines While true combination vaccines are still in development, the same convenience principle applies to coadministration: fewer trips, fewer barriers, more people protected.
What About Adding a Third Vaccine to the Visit
If you are over 60 and also due for an RSV vaccine, or if your doctor has suggested a pneumococcal vaccine, you may wonder whether stacking three shots crosses some kind of line. The evidence on this is thinner but generally reassuring. The study that tested coadministration of an mRNA COVID vaccine with both a flu shot and a pneumococcal polysaccharide vaccine found that neutralizing antibody responses to COVID were preserved even in the three-vaccine group, matching the two-vaccine and single-vaccine groups almost exactly.6PubMed Central. Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines The anti-spike IgG fold-rise was lower in the triple group compared to COVID vaccine alone, but again, the metric that matters most for actual protection, neutralization, was unaffected.
The broader review of adult vaccine coadministration literature supports the idea that multiple non-live vaccines can be given in a single visit without meaningful immunological interference, consistent with the long-standing pediatric practice of administering several vaccines at once.2PubMed Central. Adult Vaccine Coadministration Is Safe, Effective, and Acceptable: Results of a Survey of the Literature If your provider offers to give you everything you are due for in one sitting, the science supports that approach. Side effects may be a bit more noticeable with three injections than with two, so plan your schedule accordingly if you know you are sensitive.
Common Misconceptions About Vaccine Spacing
One persistent belief is that your immune system needs “recovery time” between vaccines, similar to how you would not run two marathons on back-to-back days. The analogy is appealing but inaccurate. Your immune system is not a single muscle that can be overworked. It is a distributed network of cells and proteins that can recognize and respond to multiple threats simultaneously. You encounter dozens of new antigens every day in your food, your environment, and your own body. Two more from vaccines barely registers in that context.
Another misconception is that the early pandemic guidance to space COVID vaccines away from other vaccines reflected a genuine immunological concern. It did not. That recommendation existed because COVID vaccines were brand new and regulators wanted to cleanly attribute any side effects to the right vaccine. Once enough safety data accumulated, the spacing recommendation was dropped. The cautious approach was never based on evidence of interference; it was a data-collection strategy that outlived its usefulness but left a lasting impression on the public.
A third myth is that getting two shots means double the side effects. As the surveillance data shows, the actual increase is modest: roughly an 8-11% higher odds of reporting systemic symptoms like fatigue or headache compared to the COVID booster alone.8JAMA Network Open. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US That is not “double.” It is a small, additive bump. Most people who feel fine after one shot will feel fine, or close to it, after two.
Combination Vaccines on the Horizon
Several pharmaceutical companies are working on single-shot vaccines that combine COVID and flu antigens into one injection. These would eliminate the coadministration question entirely by making both vaccines a single product. Early-phase trials have been underway, and interest from underserved populations suggests strong demand for the convenience a combination product would offer.14PubMed Central. Underserved population acceptance of combination influenza-COVID-19 booster vaccines Until those products reach the market, coadministration of two separate shots remains the simplest way to get both vaccines in one trip. The immunological groundwork showing that these vaccines play well together is, in a sense, already doing the science that combination vaccines will eventually make convenient by default.